Rosetta Genomics Overview
- Year Founded
-
2000
- Status
-
Out of Business
- Employees
-
86
- Latest Deal Type
-
Liquidation
Rosetta Genomics General Information
Description
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.
Contact Information
Website
www.rosettagx.comCorporate Office
- 10 Plaut Street, Science Park
- POB 4059
- Rehovot 76706
- Israel
Corporate Office
- 10 Plaut Street, Science Park
- POB 4059
- Rehovot 76706
- Israel
Rosetta Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Bankruptcy: Liquidation | 31-May-2018 | Completed | Bankruptcy: Liquidation | |||
| 12. Buyout/LBO (Add-on) | 30-May-2018 | Cancelled | Generating Revenue | |||
| 11. PIPE | 01-Dec-2016 | Completed | Generating Revenue | |||
| 10. PIPE | 14-Oct-2015 | Completed | Generating Revenue | |||
| 9. 2PO | 03-Aug-2012 | Completed | Generating Revenue | |||
| 8. PIPE | 29-Feb-2012 | Completed | Generating Revenue | |||
| 7. PIPE | 27-Oct-2011 | Completed | Generating Revenue | |||
| 6. PIPE | 07-Mar-2011 | Completed | Generating Revenue | |||
| 5. PIPE | 16-Apr-2009 | $8M | $45.5M | Completed | Generating Revenue | |
| 4. IPO | 27-Feb-2007 | $26.2M | $37.5M | Completed | Generating Revenue |
Rosetta Genomics Comparisons
Industry
Financing
Details
Rosetta Genomics Competitors (16)
One of Rosetta Genomics’s 16 competitors is Foundation Medicine, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Foundation Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Veracyte | Formerly VC-backed | South San Francisco, CA | ||||
| Cellectis | Formerly VC-backed | Paris, France | ||||
| Abbott | Corporation | Abbot Park, IL | ||||
| Guardant Health | Formerly VC-backed | Palo Alto, CA |
Rosetta Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Rosetta Genomics Patents
Rosetta Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20180043036-A1 | Lipid assemblies and uses thereof and some ph and electrostatic modulating lipids to be used in said assemblies | Active | 04-Feb-2015 | ||
| CA-2945531-A1 | Mirna expression signature in the classification of thyroid tumors | Active | 13-May-2014 | ||
| CA-2945531-C | Mirna expression signature in the classification of thyroid tumors | Inactive | 13-May-2014 | ||
| US-20190300963-A1 | Mirna expression signature in the classification of thyroid tumors | Inactive | 13-May-2014 | ||
| US-20170356055-A1 | Mirna expression signature in the classification of thyroid tumors | Inactive | 13-May-2014 | C12Q1/6886 |
Rosetta Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Rosetta Genomics Acquisitions (2)
Rosetta Genomics’s most recent deal was a Merger/Acquisition with CynoGen for . The deal was made on 13-Apr-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CynoGen | 13-Apr-2015 | Merger/Acquisition | Laboratory Services (Healthcare) | ||
| Parkway Clinical Laboratories | 24-Jul-2008 | Merger/Acquisition | Laboratory Services (Healthcare) |
Rosetta Genomics FAQs
-
When was Rosetta Genomics founded?
Rosetta Genomics was founded in 2000.
-
Where is Rosetta Genomics headquartered?
Rosetta Genomics is headquartered in Rehovot, Israel.
-
What is the size of Rosetta Genomics?
Rosetta Genomics has 86 total employees.
-
What industry is Rosetta Genomics in?
Rosetta Genomics’s primary industry is Pharmaceuticals.
-
Is Rosetta Genomics a private or public company?
Rosetta Genomics is a Private company.
-
What is Rosetta Genomics’s current revenue?
The current revenue for Rosetta Genomics is .
-
How much funding has Rosetta Genomics raised over time?
Rosetta Genomics has raised $103M.
-
Who are Rosetta Genomics’s competitors?
Foundation Medicine, Veracyte, Cellectis, Abbott, and Guardant Health are some of the 16 competitors of Rosetta Genomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
